• Pagaya Technologies has recently closed a US$600 million AAA-rated personal loan ABS (PAID 2026-2) and a US$368 million PAID-2026-R2 resecuritization, the latter marking its first Fitch-rated transaction and expanding its ABS investor base.
• These transactions highlight Pagaya’s ability to attract repeat and new institutional investors while adding a new rating agency, which may broaden access to capital and reinforce confidence in its ABS funding platform.
• We’ll now examine how adding a Fitch rating to the latest PAID resecuritization could influence Pagaya’s investment narrative and funding outlook.

We've uncovered the 11 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.

Pagaya Technologies Investment Narrative Recap

To own Pagaya, you need to believe its AI underwriting and ABS funding engine can keep attracting capital and partners without running into outsized regulatory or credit problems. The latest US$600 million AAA ABS and US$368 million Fitch rated resecuritization support the near term catalyst of funding diversification, while the biggest risk remains regulatory and partner concentration: if a major bank or funding partner stepped back, these deals alone would not fully offset the impact.

Among recent updates, the expansion and repricing of Pagaya’s revolving credit facility to US$132 million, with lower spreads and more lenders, ties directly into this funding story. Together with the new Fitch rated PAID 2026 R2, it underlines how Pagaya is widening its funding channels and potentially lowering its blended cost of capital, which matters for supporting product rollouts and absorbing any pressure from tighter credit or slower loan demand.

Yet beneath the growing ABS volumes, investors should be aware that concentrated partner exposure could quickly matter if...

Pagaya Technologies’ narrative projects $1.8 billion revenue and $311.7 million earnings by 2028. This requires 17.0% yearly revenue growth and a $594.1 million earnings increase from -$282.4 million today.

Uncover how Pagaya Technologies' forecasts yield a $38.18 fair value, a 160% upside to its current price.

Exploring Other Perspectives

Some of the lowest ranked analysts paint a much harsher picture, assuming only about US$1.7 billion of revenue and roughly US$223 million of earnings by 2028, so this new Fitch rated ABS deal may or may not shift their concerns about partner dependence and commoditization of AI underwriting, which is exactly why you should compare several viewpoints rather than rely on a single narrative.

Explore 9 other fair value estimates on Pagaya Technologies - why the stock might be worth just $20.00!

Reach Your Own Conclusion

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Pagaya Technologies research is our analysis highlighting 4 key rewards and 2 important warning signs that could impact your investment decision.
• Our free Pagaya Technologies research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Pagaya Technologies' overall financial health at a glance.

Looking For Alternative Opportunities?

These stocks are moving-our analysis flagged them today. Act fast before the price catches up:

• AI is about to change healthcare. These 35 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 19 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.
• Uncover the next big thing with 29 elite penny stocks that balance risk and reward.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.